240 related articles for article (PubMed ID: 33471378)
1. The role of innate immunity and inflammation in Parkinson´s disease.
Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
[TBL] [Abstract][Full Text] [Related]
2. Periphery and brain, innate and adaptive immunity in Parkinson's disease.
Harms AS; Ferreira SA; Romero-Ramos M
Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.
Lee H; James WS; Cowley SA
Biochem Soc Trans; 2017 Feb; 45(1):131-139. PubMed ID: 28202666
[TBL] [Abstract][Full Text] [Related]
4. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
5. The role of innate and adaptive immunity in Parkinson's disease.
Kannarkat GT; Boss JM; Tansey MG
J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
[TBL] [Abstract][Full Text] [Related]
6. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
Gardai SJ; Mao W; Schüle B; Babcock M; Schoebel S; Lorenzana C; Alexander J; Kim S; Glick H; Hilton K; Fitzgerald JK; Buttini M; Chiou SS; McConlogue L; Anderson JP; Schenk DB; Bard F; Langston JW; Yednock T; Johnston JA
PLoS One; 2013; 8(8):e71634. PubMed ID: 24058406
[TBL] [Abstract][Full Text] [Related]
7. Innate and adaptive immune responses in Parkinson's disease.
Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation in Parkinson's disease.
Lee JK; Tran T; Tansey MG
J Neuroimmune Pharmacol; 2009 Dec; 4(4):419-29. PubMed ID: 19821032
[TBL] [Abstract][Full Text] [Related]
9. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
10. TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model.
Campolo M; Paterniti I; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
Brain Behav Immun; 2019 Feb; 76():236-247. PubMed ID: 30550933
[TBL] [Abstract][Full Text] [Related]
11. Neural and immune mechanisms in the pathogenesis of Parkinson's disease.
Blandini F
J Neuroimmune Pharmacol; 2013 Mar; 8(1):189-201. PubMed ID: 23378275
[TBL] [Abstract][Full Text] [Related]
12. Updates on immunity and inflammation in Parkinson disease pathology.
Joshi N; Singh S
J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
[TBL] [Abstract][Full Text] [Related]
13. Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor.
Lesteberg KE; Beckham JD
Viral Immunol; 2019; 32(1):38-47. PubMed ID: 30222521
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and adaptive immunity in Parkinson's disease.
Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
[TBL] [Abstract][Full Text] [Related]
15. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.
Sanchez-Guajardo V; Barnum CJ; Tansey MG; Romero-Ramos M
ASN Neuro; 2013 Apr; 5(2):113-39. PubMed ID: 23506036
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.
Peralta Ramos JM; Iribarren P; Bousset L; Melki R; Baekelandt V; Van der Perren A
Front Immunol; 2019; 10():80. PubMed ID: 30761145
[TBL] [Abstract][Full Text] [Related]
17. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and Parkinson's disease.
Wersinger C; Sidhu A
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):221-42. PubMed ID: 14561187
[TBL] [Abstract][Full Text] [Related]
19. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
Gelders G; Baekelandt V; Van der Perren A
J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
